NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240116. A total of 6 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Warberg Asset Management LLC | 77,709 | $15,390 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CLEAR STREET LLC | 58,672 | $14 | 0.00% |
| Hudson Bay Capital Management LP | 87,734 | $20,732 | 0.00% |
| Citadel Advisors | 37,934 | $8,964 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 100 | $16 | 0.00% |
This page lists NEUROSENSE THERAPEUTICS LTD's shareholders in Q2 2023. To view NEUROSENSE THERAPEUTICS LTD's shareholder history, click here.